Study Completed

Contraception

Bayer Identifier:

16903

ClinicalTrials.gov Identifier:

NCT02349815

EudraCT Number:

Not Available

EU CT Number:

Not Available

JAYDESS Drug Utilization Study in Sweden

Trial purpose

- To describe characteristics (demographic, clinical, social) of first time users of Jaydess
- To estimate the duration of use of Jaydess
- To study switching patterns, e.g. what are the hormonal contraceptive methods used before and what are the methods after discontinuing Jaydess
- To study off-label use of Jaydess

Key Participants Requirements

Sex

Female

Age

18 - 64 Years

Trial summary

Enrollment Goal

10000

Trial Dates

January 2017 - April 2022

Phase

N/A

Could I Receive a placebo

Products

Skyla (Levonorgestrel, BAY86-5028)

Accepts Healthy Volunteer

Where to participate

Status	Institution	Location
Completed	Many Locations	Many Locations, Sweden

Primary Outcome

Duration of use of JAYDESS
Time Frame:
Up to 6 years
Safety Issue:
No
Indication for use
Time Frame:
At insertion
Safety Issue:
No

Secondary Outcome

Age at insertion and removal
Time Frame:
Up to 6 years
Safety Issue:
No

Trial design

Pharmacoepidemiological study (Drug Utilization Study) of JAYDESS use in routine clinical practice in Sweden

Trial Type

Observational

Intervention Type

Drug

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find information for studies related to Bayer products. To find this study enter the ClinicalTrials.gov identifier (NCT) number or Bayer Study Identifier (ID) in the search field.